Treatment of children with attention-deficit/hyperactivity disorder: Evaluating a switch from conventional methylphenidate to the once-daily OROS formulation of methylphenidate

被引：0
|
作者：
Santosh, P [1 ]
机构：
[1] Maudsley Hosp & Inst Psychiat, Inst Psychiat, London SE5 8AZ, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)92359-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [41] Use of methylphenidate in attention-deficit hyperactivity disorder
    Jean-Tron, Maria G.
    Marquez-Gonzalez, Horacio
    Barragan-Perez, Eduardo
    Barajas-Nava, Leticia A.
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2020, 77 (01): : 42 - 45
  • [42] A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (The COMACS study)
    Swanson, JM
    Wigal, SB
    Wigal, T
    Sonuga-Barke, EJS
    Greenhill, LL
    Biederman, J
    Kollins, S
    Nguyen, AS
    DeCory, HH
    Dirksen, SJH
    Hatch, SJ
    PEDIATRICS, 2004, 113 (03) : E206 - E216
  • [43] Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder
    Sugrue, David
    Bogner, Robin
    Ehret, Megan J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (14) : 1163 - 1170
  • [44] USE OF METHYLPHENIDATE FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    LEXCHIN, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1990, 143 (03) : 171 - 171
  • [45] Effect of Methylphenidate on Motivation in Children With Attention-Deficit/Hyperactivity Disorder
    Chelonis, John J.
    Johnson, Teresa A.
    Ferguson, Sherry A.
    Berry, Kimberly J.
    Kubacak, Brian
    Edwards, Mark C.
    Paule, Merle G.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2011, 19 (02) : 145 - 153
  • [46] USE OF METHYLPHENIDATE FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    BROSTE, SM
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1990, 143 (10) : 995 - &
  • [47] Methylphenidate for Attention-Deficit/Hyperactivity Disorder Reply
    Storebo, Ole Jakob
    Simonsen, Erik
    Gluud, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 995 - 995
  • [48] Methylphenidate transdermal system - In attention-deficit hyperactivity disorder in children
    Anderson, Vanessa R.
    Scott, Lesley J.
    DRUGS, 2006, 66 (08) : 1117 - 1126
  • [49] Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
    Chou, Wen-Jiun
    Wang, Liang-Yen
    Lin, Chien-Ho
    Liang, Sun-Yuan
    Chen, Vincent Chin-Hung
    Hou, Yuh-Ming
    Huang, Rong-Rong
    Chou, Miao-Chun
    Shang, Chi-Yung
    Ho, Chi-Pui
    Lai, Meng-Chuan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2783 - 2791
  • [50] Methylphenidate in adults with attention-deficit/hyperactivity disorder
    Koesters, M.
    Weinmann, S.
    Becker, T.
    NERVENARZT, 2007, 78 (09): : 1065 - 1066
12345